PubMed Health⌕ Search

Biomedical subjects

B Pettersen

Publications and source records attributed to B Pettersen.

10 recordsLinked to original sources

[Infusion of barbiturates as a compenent in the treatment of refractory pain in patients with terminal cancer].

Four patients with advanced cancer were referred to the Pain Team because of refractory pain symptoms. They received intravenous barbiturates prior to death. All attempts at palliative treatment had been exhausted. The symptoms were described by patients and family as unendurable. After adding intravenous thiopental, relief and tranquility were achieved. All four patients died peacefully. The need to sedate to a state of unconsciousness or semi-consciousness to relieve symptoms in dying cancer patients is extremely rare. After all viable alternatives have been explored, titrated barbiturate infusion as an adjuvant may fill a void in the care of especially challenging patients as they approach death from terminal cancer.

Anesthetics, Intravenous↗

[Complaints--a source of quality assurance even in primary health care].

In this article we discuss the handling of complaints from consumers of primary health care. We present data from municipalities on the frequency of complaints and the ways of handling them. In primary health care complaints are not handled systematically, and are seldom referred to in internal meetings. We conclude that complaints and other reactions from consumers should be used in quality control in primary health care.

Norway↗

Skin injury in an infant with pulse oximetry.

An 11-month-old girl received 23 propofol anaesthetics for radiation treatment of a retinoblastoma. After the first two anaesthetics, a skin injury appeared on the pulp of the toes, where the light source of a pulse oximeter probe had been placed. During the remaining 21 anaesthetics the light source of the probe was placed over the nails, and no other skin lesions occurred. Examination of the equipment revealed no malfunction. Thermal and other possible causes of the skin injury are discussed.

Eye Neoplasms↗

Successful treatment of chronic pancreatitis pain with interpleural analgesia.

Interpleural analgesia has recently been shown to be effective in the management of various chronic pain syndromes. We have used interpleural analgesia successfully in 11 patients with severe chronic pancreatitis of 24-38 months' duration. Daily injections of 30 ml of 0.5 per cent bupivacaine with epinephrine 5 mu.ml-1, were given through a percutaneously inserted pleural catheter over a five- to ten-day period. Patients have remained pain-free during follow up which ranges from 24 to 40 weeks. This method of providing analgesia for the patient suffering from the pain of chronic pancreatitis is simple, safe, effective and can be provided on an outpatient basis.

Adult↗

Interpleural analgesia in the treatment of severe thoracic postherpetic neuralgia.

Effective, long-lasting pain relief was produced in 26 patients suffering from severe thoracic postherpetic neuralgia by intermittent administration of local anesthetics into the pleural space through a percutaneously placed interpleural catheter. The duration of treatment varied from seven to 21 days. During this period, 30 ml of 0.5% bupivacaine with epinephrine (5 micrograms/ml) were injected every 24 hours. The injections were continued for three days after the patients were pain free or had reached an analgesic plateau. All patients achieved good to excellent pain relief. During a follow-up period of five to 15 months, their level of pain has not increased from the level achieved at the end of the treatment program.

Aged↗